Our Mission

We are a division of CobiCure, a pediatrics-focused nonprofit company within Advancium Health Network, committed to bringing life-changing therapeutics to patients by utilizing philanthropic funding and strategic partnerships. We manage a portfolio of projects addressing high-impact needs in the underserved markets of pediatrics and rare diseases.

Pediatric cancers and rare diseases are underfunded and underserved:

More than 300M children worldwide suffer from a rare disease. ¹
95% of rare diseases do not have approved treatments. ²
30% of children with a rare disease won’t live to see their fifth birthday. ³

Source
1 - www.rarediseaseday.org
2 & 3 - www.rarediseases.org

We are building an accelerator to deliver life-changing products to children by:

In-licensing, acquiring or co-developing therapeutic assets that will reduce patient morbidity and mortality

Partnering with leading experts and funders with similar goals to leverage exceptional skills and resources

Advancing assets through late-stage R&D, clinical trials, and regulatory clearance/approval

News at CobiCure Therapeutics

Children Can’t Wait: A Night That Proved Why

CobiCure’s inspiring NYC event brought together experts to accelerate treatments for children with rare diseases. Because every kid deserves care now, not later.

Advancium Health Network Names Michele Cleary CEO to Drive Next Phase of Pediatric Healthcare Innovation

Advancium Health Network appoints Michele Cleary, PhD, as CEO to advance its mission of faster pediatric treatments and devices for rare diseases through Advancium and CobiCure. Her leadership will fuel key partnerships and urgent progress for affected families.

Unlocking Stranded Innovation for Children: How CobiCure Is Reimagining Access to Life-Changing Therapies

Aligned with ASGCT's vision for advancing "stranded innovation", CobiCure is rescuing promising but commercially abandoned therapies for children with rare diseases.

Changing the Business Model for Pediatric Rare Diseases CobiCure’s Mission: Overcoming Barriers to Deliver Effective Treatments to Children Board Spotlight: Gary Brewster on Financial Resilience in Rare Disease R&D and Efficiently Translating Research into Patient Access Real Stories: Why CobiCure’s Mission Matters to Our CEO, Mark Veich